AstraZeneca faces new import tax fine in China of up to US$8-million

theglobeandmail.com/business/international-business/article-astrazeneca-faces-new-import-tax-fine-in-china-of-up-to-us8-million

AstraZeneca AZN-Q may face a fine of up to $8-million in China over suspected unpaid taxes related to the import of its breast cancer drug Enhertu, the drug maker said on Tuesday, as it works to revive business in its second-biggest market after scandals.
Despite boasting a strong…

This story appeared on theglobeandmail.com, 2025-04-29 11:06:07.
The Entire Business World on a Single Page. Free to Use →